The document summarizes Fresenius' acquisition of Quirónsalud, the largest private hospital group in Spain. Key points include: Quirónsalud is a market leader with strong growth prospects; the combination will form a powerful platform to transfer knowledge and best practices; substantial cost and growth synergies are expected; and the acquisition is highly accretive and leverage can be reduced within 1.5 years. Financial details note a purchase price of €5.76 billion and projected synergies of €50 million annually.